Charts Day One Biopharmaceuticals, Inc.

Stocks

Delayed Nasdaq 16:00:00 2026-04-22 EDT			5-day change	1st Jan Change
21.53 ^USD	+0.19%		-.--%	+131.01%

05-08	Day One Biopharmaceuticals, Inc. Announces Completion Of Enrollment In Pivotal Phase 3 Firefly-2 Trial Of Tovorafenib As Front-Line Treatment For Pediatric Low-Grade Glioma	CI
04-26	Day One Biopharmaceuticals, Inc.(NasdaqGS:DAWN) dropped from Russell 2500 Index	CI

ProRealTime Chart